SEARCH

SEARCH BY CITATION

  • 1
    Evans CP, Gange S, Khalid A, Eason A, Narayan P. The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate. BJU Int 1996; 78: 42631